503P - EPI-7386 is a novel N-terminal domain androgen receptor inhibitor for the treatment of prostate cancer
| Autor: | Moigne, R Le, Banuelos, C.A., Mawji, N.R., Tam, T., Wang, J., Jian, K., Andersen, R.J., Cesano, A., Sadar, M.D., Zhou, H.-J., Virsik, P. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v189-v190 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|